Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.7 USD | -0.38% | +3.71% | +22.46% |
10:10am | Crane NXT's Q1 Adjusted Earnings, Revenue Decline; 2024 Revenue Outlook Improved | MT |
May. 08 | (CXT) CRANE NXT Sees Fiscal Year 2024 EPS Range $4.10 - $4.35 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.46% | 8.27B | |
+9.21% | 15.19B | |
-25.61% | 11.22B | |
+1.87% | 7.08B | |
+37.73% | 2.01B | |
+6.68% | 1.6B | |
+24.14% | 960M | |
+10.46% | 927M | |
+8.37% | 751M | |
-5.03% | 676M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection